VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)

Feliu, J; Garcia-Carbonero, R; Capdevila, J; Guasch, I; Alonso-Orduna, V; Lopez, C; Garcia-Alfonso, P; Castanon, C; Sevilla, I; Cerezo, L; Conill, C; Quintana-Angel, B; Sanchez, ME; Ghanem, I; Martin-Richard, M; Lopez-Gomez, M; Leon, A; Caro, M; Fernandez, T; Maurel, J – 2020